Intrathecal Administration of scAAV9/JeT-GAN for the Treatment of Giant Axonal Neuropathy

Key facts

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Principal Investigator

Carsten G Bonnemann, M.D., M.D

National Institute of Neurological Disorders and Stroke (NINDS)

Intervention

scAAv9/JeT-GAN(genetic)

Enrollment

14 enrolled

Eligibility

3-99 years · All sexes

Timeline

2015 – 2035

Study locations (1)

• National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Giant axonal neuropathy

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1NCT06347770
  The Effect of Oral Gan Shuangbi During the Perinatal Period on the Recovery of Intestinal Function After Cesarean Section in Pregnant Women- A Multicenter, Double-blind, Randomized Controlled Clinical Trial
  Zhe Li

See all trials for Giant axonal neuropathy →